Related Experiment Video
Updated: Jun 12, 2026
07:30
Learning Modern Laryngeal Surgery in a Dissection Laboratory
Published on: March 18, 2020
Vertical partial hemilaryngectomy with reconstruction by false cord imbrication
Kuauhyama Luna-Ortiz1, Eunice Campos-Ramos, Verónica Villavicencio-Valencia
1Department of Head and Neck Surgery, Instituto Nacional de Cancerología (México), Mexico City, Mexico. kuauhyama@yahoo.com.mx
ANZ Journal of Surgery
|June 19, 2010
Summary
Vertical partial hemilaryngectomy with false cord reconstruction offers excellent oncological control and functional outcomes for early glottic cancers. This procedure results in high survival rates and good voice quality with minimal complications.
Area of Science:
- Otolaryngology
- Head and Neck Surgery
- Surgical Oncology
Background:
- Evaluating outcomes of vertical partial hemilaryngectomy (VPHL) with false cord reconstruction.
- Assessing survival, disease-free period, complications, and functional results.
- Focus on early glottic cancer treatment.
Purpose of the Study:
- To evaluate global survival, disease-free period, complications, evolution, and function in vertical partial hemilaryngectomy (VPHL) plus reconstruction with false cord.
- To determine the efficacy of VPHL with false cord imbrication for early glottic cancers.
Main Methods:
- Descriptive and retrospective study conducted at a tertiary care medical center.
- Eight patients with early glottic cancer (T1 and T2) underwent VPHL plus false cord imbrication.
- Data collected on survival, complications, functional status (PSS-HNC, Karnofsky), and voice quality.
Main Results:
- Patients included stages I (50%), II (37.5%), and III (12.5%).
- Average oral feeding initiation: 3 days; tracheostomy removal: 2.1 days; hospital stay: 3.3 days.
- High functional status (PSS-HNC 91-97, Karnofsky 100 at 1 year), 87.5% normal voice, 100% global survival, and 71% disease-free at 3 years.
Conclusions:
- VPHL with false cord imbrication is an excellent therapeutic option for early glottic cancers.
- Demonstrates significant functional advantages, including audible and intelligible voice, without compromising oncological control.
- Recurrence management options are available, supporting the procedure's viability.
